MYC and osteosarcoma: In this study, we demonstrated that the administration of diosmetin on osteosarcoma cells like Saos-2 and U2SO cells significantly inhibited cell proliferation while promoted apoptosis, with remarkable reduction of STAT3, p-STAT3 and its downstream protein c-Myc levels in a dose-dependent manner.